These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31222471)

  • 21. Expression and membrane assembly of a transmembrane region from Neu.
    Jones DH; Ball EH; Sharpe S; Barber KR; Grant CW
    Biochemistry; 2000 Feb; 39(7):1870-8. PubMed ID: 10677238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A putative molecular-activation switch in the transmembrane domain of erbB2.
    Fleishman SJ; Schlessinger J; Ben-Tal N
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15937-40. PubMed ID: 12461170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.
    Burke CL; Stern DF
    Mol Cell Biol; 1998 Sep; 18(9):5371-9. PubMed ID: 9710621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
    He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
    J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of hydrophilic substitutions and anionic lipids upon the transverse positioning of the transmembrane helix of the ErbB2 (neu) protein incorporated into model membrane vesicles.
    Shahidullah K; Krishnakumar SS; London E
    J Mol Biol; 2010 Feb; 396(1):209-20. PubMed ID: 19931543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMR.
    Elkins MR; Williams JK; Gelenter MD; Dai P; Kwon B; Sergeyev IV; Pentelute BL; Hong M
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):12946-12951. PubMed ID: 29158386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer.
    Garnier N; Crouzy S; Genest M
    J Biomol Struct Dyn; 2003 Oct; 21(2):179-200. PubMed ID: 12956604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong dimerization of wild-type ErbB2/Neu transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma membranes.
    Placone J; He L; Del Piccolo N; Hristova K
    Biochim Biophys Acta; 2014 Sep; 1838(9):2326-30. PubMed ID: 24631664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.
    He L; Shobnam N; Hristova K
    Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of High pH and Cholesterol on Single Arginine-Containing Transmembrane Peptide Helices.
    Thibado JK; Martfeld AN; Greathouse DV; Koeppe RE
    Biochemistry; 2016 Nov; 55(45):6337-6343. PubMed ID: 27782382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor transmembrane domain: 2H NMR implications for orientation and motion in a bilayer environment.
    Jones DH; Barber KR; VanDerLoo EW; Grant CW
    Biochemistry; 1998 Nov; 37(47):16780-7. PubMed ID: 9843449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transmembrane domain of Neu in a lipid bilayer: molecular dynamics simulations.
    van der Ende BM; Sharom FJ; Davis JH
    Eur Biophys J; 2004 Nov; 33(7):596-610. PubMed ID: 15197512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Veratridine binding to a transmembrane helix of sodium channel Na
    Niitsu A; Egawa A; Ikeda K; Tachibana K; Fujiwara T
    Bioorg Med Chem; 2018 Nov; 26(21):5644-5653. PubMed ID: 30389410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation.
    Burke CL; Lemmon MA; Coren BA; Engelman DM; Stern DF
    Oncogene; 1997 Feb; 14(6):687-96. PubMed ID: 9038376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE.
    Houliston RS; Hodges RS; Sharom FJ; Davis JH
    FEBS Lett; 2003 Jan; 535(1-3):39-43. PubMed ID: 12560075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure prediction of the dimeric neu/ErbB-2 transmembrane domain from multi-nanosecond molecular dynamics simulations.
    Sajot N; Genest M
    Eur Biophys J; 2000; 28(8):648-62. PubMed ID: 10663532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for an alpha-helix --> pi-bulge helicity modulation for the neu/erbB-2 membrane-spanning segment. A 1H NMR and circular dichroism study.
    Goetz M; Carlotti C; Bontems F; Dufourc EJ
    Biochemistry; 2001 May; 40(21):6534-40. PubMed ID: 11371217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic molecular dynamics searching in a lipid bilayer: application to the glycophorin A and oncogenic ErbB-2 transmembrane domains.
    Beevers AJ; Kukol A
    J Mol Graph Model; 2006 Oct; 25(2):226-33. PubMed ID: 16434222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions.
    Bragin PE; Mineev KS; Bocharova OV; Volynsky PE; Bocharov EV; Arseniev AS
    J Mol Biol; 2016 Jan; 428(1):52-61. PubMed ID: 26585403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligomerization of the EGF receptor transmembrane domain: a 2H NMR study in lipid bilayers.
    Jones DH; Rigby AC; Barber KR; Grant CW
    Biochemistry; 1997 Oct; 36(41):12616-24. PubMed ID: 9376368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.